CoChat

Agonism and allosterism: the pharmacology of the free fatty acid receptors FFA2 and FFA3

Open access
Milligan, Graeme, Stoddart, Leigh A., Smith, Nicola J. · 2009 · British Journal of Pharmacology
Cited by 68

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

The free fatty acid receptors FFA2 and FFA3 are recently de‐orphanized G protein‐coupled receptors that share a group of short‐chain free fatty acids as endogenous ligands. The expression of FFA2 and FFA3 by immune cells, in parts of the gastro‐intestinal tract and by white adipocytes has suggested their potential as therapeutic targets in conditions including inflammation and obesity. However, although FFA2 and FFA3 display distinct structure–activity relationships for stimulation by short‐chain free fatty acids, the overlap between these endogenous agonists and the lack of synthetic small molecule ligands that display selectivity between these two receptors has, until recently, hindered efforts to resolve their individual functions. Recently, chloro‐α‐(1‐methylethyl)‐N‐2‐thiazolylbenzeneacetamide has been described as an FFA2 selective ago‐allosteric ligand, not only being a direct agonist but also acting as a positive allosteric modulator of the function of short‐chain free fatty acids at FFA2. Mutation of a pair of key arginine residues near the top of transmembrane domains V and VII of both FFA2 and FFA3 eliminates the function of short‐chain free fatty acids but is without effect on the direct agonist action of chloro‐α‐(1‐methylethyl)‐N‐2‐thiazolylbenzeneacetamide at FFA2, confirming the distinct nature of the binding site of the ago‐allosteric regulator from the orthosteric binding site for free fatty acids. An understanding of structure–activity relationships for ligands related to chloro‐α‐(1‐methylethyl)‐N‐2‐thiazolylbenzeneacetamide is likely to provide greater insight into the mode of action and site of binding of this ligand, but further FFA2 and FFA3 selective ligands, preferably with higher potency/affinity, will be required to fully explore the physiological function of these receptors.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1476-5381.2009.00421.x

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

See all 68

Metadata

Authors
Milligan, G., Stoddart, L. A., & Smith, N. J.
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
2009-08-25
Volume
158
Issue
1
Pages
146-153
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W1998253541
Cited by
68
References
9
FWCI
1.44
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Agonism and allosterism: the pharmacology of the free fatty acid receptors FFA2 and FFA3. https://app.cochat.ai/papers/10.1111/j.1476-5381.2009.00421.x
The paper
Milligan, G., Stoddart, L. A., & Smith, N. J. (2009). Agonism and allosterism: the pharmacology of the free fatty acid receptors FFA2 and FFA3. British Journal of Pharmacology. https://doi.org/10.1111/j.1476-5381.2009.00421.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.